Genetics of chronic obstructive pulmonary disease
- PMID: 18268927
- PMCID: PMC2699975
Genetics of chronic obstructive pulmonary disease
Abstract
Chronic obstructive pulmonary disease (COPD) is a complex disease with multifactorial background, based on the interaction of environmental and genetic factors. Environmental factors are clearly related to the development of the disease. However, family and twin studies suggested genetics factors to be one of the important determinants for the development of COPD. Different approaches have been used to identify genes of interest. Genomewide linkage analysis found areas of interest on different chromosomes, with some genes located in this regions being identified and replicated as susceptibility genes. Numerous of candidate genes that could be linked to disease pathogenesis have been implicated in COPD genetics. However, the candidate gene approach is often limited by inconsistent results in other study populations. Recently, a combination of different methods is used giving more evidence for some candidate genes, including TGFbeta-1, Surfactant, SERPINE2 and microsomal epoxide hydrolase. In the future ongoing exact phenotype definition, combination of several approaches, genome-wide association studies and animal model genetics will lead to new insights into the genetics of COPD, with epigenetic factors needs to be further investigated and considered in concert with genetic findings.
Figures


References
-
- Astemborski JA, Beaty TH, et al. Variance components analysis of forced expiration in families. Am J Med Genet. 1985;21:741–53. - PubMed
-
- Baranova H, Perriot J, et al. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet. 1997;99:822–6. - PubMed
-
- Bartsch H, Castegnaro M, et al. Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer. Toxicol Lett. 1992:64–65. Spec No:477–83. - PubMed
-
- Beck GJ, Doyle CA, et al. Smoking and lung function. Am Rev Respir Dis. 1981;123:149–55. - PubMed
-
- Benetazzo MG, Gile LS, et al. alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. Respir Med. 1999;93:648–54. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous